The clinics atmosphere was clean, modern, and calming, which immediately put me at ease
Clinical Benefits Beyond Blood Sugar Control The potential anti-inflammatory properties of GLP-1 receptor agonists may contribute to their demonstrated cardiovascular and renal benefits , which have been observed in large-scale cardiovascular outcome trials
Pauling This Pharmacology Consult will focus on GLP-1 receptor agonists that are currently FDA approved for weight loss, including semaglutide (Wegovy, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk), but other FDA-approved options exist, such as orlistat, naltrexone/bupropion and phentermine/topiramate
Do I need to follow a diet or exercise plan
Most people notice reduced appetite within 7-14 days of the first injection, though effects strengthen with each dose increase
Editorial standards and corrections policy This article was written by the EvenSkyn Skin Science Desk and medically reviewed by Dr